{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:06:26Z","timestamp":1793307986364,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T00:00:00Z","timestamp":1656547200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["UL 2015-2850"],"award-info":[{"award-number":["UL 2015-2850"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.coph.2022.102268","type":"journal-article","created":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T12:11:26Z","timestamp":1659269486000},"page":"102268","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Celiac disease: New therapies on the horizon"],"prefix":"10.1016","volume":"66","author":[{"given":"Tessa","family":"Dieckman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frits","family":"Koning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Bouma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2022.102268_bib1","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaw7756","article-title":"Cytokine release and gastrointestinal symptoms after gluten challenge in celiac disease","volume":"5","author":"Goel","year":"2019","journal-title":"Sci Adv"},{"key":"10.1016\/j.coph.2022.102268_bib2","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/s12916-020-01828-y","article-title":"Patient factors influencing acute gluten reactions and cytokine release in treated coeliac disease","volume":"18","author":"Tye-Din","year":"2020","journal-title":"BMC Med"},{"key":"10.1016\/j.coph.2022.102268_bib3","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/ajg.2010.10","article-title":"Mucosal recovery and mortality in adults with celiac disease after treatment with a gluten-free diet","volume":"105","author":"Rubio-Tapia","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.coph.2022.102268_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.623805","article-title":"Celiac disease causes epithelial disruption and regulatory T cell recruitment in the oral mucosa","volume":"12","author":"Sanchez-Solares","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.coph.2022.102268_bib5","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1053\/j.gastro.2019.10.006","article-title":"Identification of a \u03b3c receptor antagonist that prevents reprogramming of human tissue-resident cytotoxic T cells by IL15 and IL21","volume":"158","author":"Ciszewski","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2022.102268_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48299-7","article-title":"E40, a novel microbial protease efficiently detoxifying gluten proteins, for the dietary management of gluten intolerance","volume":"9","author":"Cavaletti","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.coph.2022.102268_bib7","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/apt.15435","article-title":"Randomised clinical trial: a placebo-controlled study of subcutaneous or intradermal NEXVAX2, an investigational immunomodulatory peptide therapy for coeliac disease","volume":"50","author":"Truitt","year":"2019","journal-title":"Aliment Pharmacol Therapeut"},{"key":"10.1016\/j.coph.2022.102268_bib8","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ebiom.2017.11.018","volume":"26","author":"Daveson","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.coph.2022.102268_bib9","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S2468-1253(17)30110-3","article-title":"Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies","volume":"2","author":"Goel","year":"2017","journal-title":"Lancet Gastroentero Hepatol"},{"key":"10.1016\/j.coph.2022.102268_sref10","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2021.03.014","article-title":"TAK-101 nanoparticles induce gluten-specific tolerance in celiac disease: a randomized, double-blind, placebo-controlled study","author":"Kelly","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2022.102268_bib11","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1053\/j.gastro.2020.01.045","article-title":"Gliadin nanoparticles induce immune tolerance to gliadin in mouse models of celiac disease","volume":"158","author":"Freitag","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2022.102268_bib12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00251-019-01141-w","article-title":"Update 2020: nomenclature and listing of celiac disease\u2013relevant gluten epitopes recognized by CD4+ T cells","volume":"72","author":"Sollid","year":"2020","journal-title":"Immunogenetics"},{"key":"10.1016\/j.coph.2022.102268_bib13","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s10620-008-0501-x","article-title":"Not T: regulatory T-cell function is impaired in celiac disease","volume":"54","author":"Granzotto","year":"2009","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.coph.2022.102268_bib14","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.jaci.2017.02.015","article-title":"Circulating gluten-specific FOXP3+CD39+ regulatory T cells have impaired suppressive function in patients with celiac disease","volume":"140","author":"Cook","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.coph.2022.102268_bib15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1124\/jpet.104.073312","article-title":"Prolyl endopeptidase-mediated destruction of T cell epitopes in whole gluten: chemical and immunological characterization","volume":"312","author":"Marti","year":"2005","journal-title":"J\u00a0Pharmacol Exp Therapeut"},{"key":"10.1016\/j.coph.2022.102268_bib16","doi-asserted-by":"crossref","first-page":"G621","DOI":"10.1152\/ajpgi.00034.2006","article-title":"Highly efficient gluten degradation with a newly identified prolyl endoprotease: implications for celiac disease","volume":"291","author":"Stepniak","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.coph.2022.102268_bib17","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S1542-3565(05)00366-6","article-title":"Effect of pretreatment of food gluten with prolyl endopeptidase on gluten-induced malabsorption in celiac sprue","volume":"3","author":"Pyle","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.coph.2022.102268_bib18","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1053\/j.gastro.2014.02.031","article-title":"Glutenase ALV003 attenuates gluten-induced mucosal injury in patients with celiac disease","volume":"146","author":"L\u00e4hdeaho","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2022.102268_bib19","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1053\/j.gastro.2016.11.004","article-title":"No difference between latiglutenase and placebo in reducing villous atrophy or improving symptoms in patients with symptomatic celiac disease","volume":"152","author":"Murray","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2022.102268_bib20","doi-asserted-by":"crossref","first-page":"5837","DOI":"10.3748\/wjg.v19.i35.5837","article-title":"Consumption of gluten with gluten-degrading enzyme by celiac patients: a pilot-study","volume":"19","author":"Tack","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.coph.2022.102268_bib21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/apt.13266","article-title":"Randomised clinical study: Aspergillus Niger-derived enzyme digests gluten in the stomach of healthy volunteers","volume":"42","author":"Salden","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.coph.2022.102268_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-13587-7","article-title":"Randomized clinical trial: effective gluten degradation by Aspergillus Niger-derived enzyme in a complex meal setting","volume":"7","author":"K\u00f6nig","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.coph.2022.102268_bib23","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.foodchem.2014.11.053","article-title":"Influence of dietary components on Aspergillus Niger prolyl endoprotease mediated gluten degradation","volume":"174","author":"Montserrat","year":"2015","journal-title":"Food Chem"},{"key":"10.1016\/j.coph.2022.102268_bib24","doi-asserted-by":"crossref","first-page":"13106","DOI":"10.1021\/jacs.5b08325","article-title":"Engineering of Kuma030: a gliadin peptidase that rapidly degrades immunogenic gliadin peptides in gastric conditions","volume":"137","author":"Wolf","year":"2015","journal-title":"J\u00a0Am Chem Soc"},{"key":"10.1016\/j.coph.2022.102268_sref25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/j.gastro.2021.03.019","article-title":"Gluten degradation, pharmacokinetics, safety, and tolerability of TAK-062, an engineered enzyme to treat celiac disease","volume":"161","author":"Pultz","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2022.102268_bib26","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/ajcn\/85.1.160","article-title":"A\u00a0prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease","volume":"85","author":"Catassi","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.coph.2022.102268_bib27","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1053\/j.gastro.2020.10.040","article-title":"Evaluating responses to gluten challenge: a randomized, double-blind, 2-dose gluten challenge trial","volume":"160","author":"Leonard","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2022.102268_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/S0016-5085(18)31861-4","article-title":"Su1161 - the oral transglutaminase 2 (TG2) inhibitor Zed1227 blocks TG2 activity in a mouse model of intestinal inflammation","volume":"154","author":"Ventura","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2022.102268_sref29","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa2032441","article-title":"A\u00a0randomized trial of a transglutaminase 2 inhibitor for celiac disease","volume":"385","author":"Schuppan","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.coph.2022.102268_bib30","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/gut.2005.068684","article-title":"Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease","volume":"55","author":"Di Sabatino","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.coph.2022.102268_bib31","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/S2468-1253(19)30264-X","article-title":"Safety and efficacy of AMG 714 in adults with coeliac disease exposed to gluten challenge: a phase 2a, randomised, double-blind, placebo-controlled study","volume":"4","author":"L\u00e4hdeaho","year":"2019","journal-title":"Lancet Gastroentero Hepatol"},{"key":"10.1016\/j.coph.2022.102268_bib32","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1053\/j.gastro.2015.02.008","article-title":"Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: a randomized controlled trial","volume":"148","author":"Leffler","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2022.102268_bib33","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1136\/gutjnl-2020-323829","article-title":"Lack of relationship of AT1001 to zonulin and prehaptoglobin-2: clinical implications","volume":"70","author":"Sollid","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.coph.2022.102268_bib34","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1136\/gutjnl-2020-323026","article-title":"Blurring the picture in leaky gut research: how shortcomings of zonulin as a biomarker mislead the field of intestinal permeability","volume":"70","author":"Massier","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.coph.2022.102268_bib35","doi-asserted-by":"crossref","first-page":"l231","DOI":"10.1136\/bmj.l231","article-title":"Enterovirus as trigger of coeliac disease: nested case-control study within prospective birth cohort","volume":"364","author":"Kahrs","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.coph.2022.102268_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.604529","article-title":"Enterovirus infections are associated with the development of celiac disease in a birth cohort study","volume":"11","author":"Oikarinen","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.coph.2022.102268_bib37","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1126\/science.aah5298","article-title":"Reovirus infection triggers inflammatory responses to dietary antigens and development of celiac disease","volume":"356","author":"Bouziat","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.coph.2022.102268_bib38","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s10620-016-4426-5","article-title":"AGY, a novel egg yolk-derived anti-gliadin antibody, is safe for patients with celiac disease","volume":"62","author":"Sample","year":"2017","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.coph.2022.102268_bib39","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1136\/gut.29.11.1564","article-title":"Low gluten diet in the treatment of adult coeliac disease: effect on jejunal morphology and serum anti-gluten antibodies","volume":"29","author":"Montgomery","year":"1988","journal-title":"Gut"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489222000959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489222000959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T19:50:28Z","timestamp":1778615428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489222000959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":39,"alternative-id":["S1471489222000959"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2022.102268","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Celiac disease: New therapies on the horizon","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2022.102268","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102268"}}